Menu Expand
Controversies in Spinal and Cranial Surgery, An Issue of Neurosurgery Clinics of North America, E-Book

Controversies in Spinal and Cranial Surgery, An Issue of Neurosurgery Clinics of North America, E-Book

Russell R. Lonser | Daniel K. Resnick

(2017)

Additional Information

Abstract

This issue of Neurosurgery Clinics focuses on Controversies in Spinal and Cranial Surgery. Article topics will include:Sacro-illiac Fusion; Interspinous Spacers;Bone Morphogenetic Protein, Platelet Concentrates and Other Biologics; MIS decompression; Pipeline flow diversion in subarachnoid hemorrhage; Direct versus indirect bypass for moyamoya disease; Management of prenatally diagnosed myelomeningocele; Management of incidental aneurysm; Surgical management of incidental low-grade glioma; and more!

Table of Contents

Section Title Page Action Price
Front Cover Cover
Controversies in Spinaland Cranial Surgery\r i
Copyright\r ii
Contributors iii
CONSULTING EDITORS iii
EDITORS iii
AUTHORS iii
Contents vii
Preface: Current Controversies in Spinal and Cranial Surgery vii
Spinal Surgery vii
The Sacroiliac Joint\r vii
Sacroiliac Fusion: Another “Magic Bullet” Destined for Disrepute\r vii
Is There Still a Role for Interspinous Spacers in the Management of Neurogenic Claudication?\r vii
Bone Morphogenic Protein Use in Spinal Surgery\r vii
Lumbar Radiculopathy in the Setting of Degenerative Scoliosis: MIS Decompression and Limited Correction are Better Options\r viii
The Case for Deformity Correction in the Management of Radiculopathy with Concurrent Spinal Deformity\r viii
Cranial Surgery\r viii
Hemicraniectomy for Ischemic and Hemorrhagic Stroke: Facts and Controversies\r viii
Direct Versus Indirect Bypass for Moyamoya Disease\r viii
Flow Diversion after Aneurysmal Subarachnoid Hemorrhage\r ix
Management of Small Incidental Intracranial Aneurysms\r ix
Surgical Management of Incidental Gliomas\r ix
Reoperation for Recurrent Glioblastoma Multiforme\r ix
Surgical Treatment of Trigeminal Neuralgia\r x
Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele\r x
NEUROSURGERY CLINICS OF NORTH AMERICA\r xi
FORTHCOMING ISSUES xi
October 2017 xi
January 2018 xi
RECENT ISSUES xi
April 2017 xi
January 2017 xi
Preface\r xiii
Current Controversies in Spinal and Cranial Surgery xiii
The Sacroiliac Joint 301
Key points 301
REFERENCES 311
Sacroiliac Fusion 313
Key points 313
INTRODUCTION 313
EPIDEMIOLOGY 313
ANATOMY 314
POTENTIAL CAUSES OF SACROILIAC JOINT PAIN 315
DIAGNOSIS 315
TREATMENT 316
SUMMARY 318
ACKNOWLEDGMENTS 318
REFERENCES 318
Is There Still a Role for Interspinous Spacers in the Management of Neurogenic Claudication? 321
Key points 321
INTRODUCTION 321
INTERSPINOUS SPACER DEVELOPMENT 322
SURGICAL VERSUS NONSURGICAL MANAGEMENT OF LUMBAR SPINAL STENOSIS 322
CONFLICTING EVIDENCE FOR INTERSPINOUS SPACER USE 323
INDICATIONS FOR INTERSPINOUS SPACER USE 324
SURGICAL TECHNIQUE/PROCEDURE 325
SURGICAL COMPLICATIONS AND MANAGEMENT 325
FUTURE DIRECTIONS AND CONSENSUS STATEMENT 325
SUMMARY 328
REFERENCES 328
Bone Morphogenic Protein Use in Spinal Surgery 331
Key points 331
INTRODUCTION 331
DEVELOPMENT OF BONE MORPHOGENIC PROTEIN 332
CONTROVERSY SURROUNDING BONE MORPHOGENIC PROTEIN USE 332
THE CURRENT USE OF BONE MORPHOGENIC PROTEIN 333
SUMMARY 334
ACKNOWLEDGMENTS 334
REFERENCES 334
Lumbar Radiculopathy in the Setting of Degenerative Scoliosis 335
Key points 335
INTRODUCTION 335
CASE EXAMPLE 336
TREATMENT RATIONALE AND DISCUSSION 337
SUMMARY 339
REFERENCES 339
The Case for Deformity Correction in the Management of Radiculopathy with Concurrent Spinal Deformity 341
Key points 341
INTRODUCTION 341
The Relationship Between Deformity and Symptomatic Radiculopathy 342
VARIABILITY IN APPROACHES TO CARE 342
DECOMPRESSION ALONE 342
DECOMPRESSION WITH LIMITED FUSION 343
DECOMPRESSION WITH EXTENSIVE FUSION 344
SUMMARY 345
REFERENCES 345
Hemicraniectomy for Ischemic and Hemorrhagic Stroke 349
Key points 349
INTRODUCTION 350
ISCHEMIC HEMISPHERIC STROKE (SUPRATENTORIAL) 350
Epidemiology 350
Pathophysiology of Malignant Stroke 350
Microscopic and cellular changes 350
Macroscopic pathology 350
Predictors of Progression 350
Time since stroke 350
National Institutes of Health stroke scale 351
Computed tomography 351
MRI 351
Best Medical Management 351
Data on Decompressive Craniectomy Before Randomized Controlled Trials 351
Data from Randomized Controlled Trials on Hemicraniectomy for Malignant Ischemic Stroke 352
Study design 352
Results of the randomized controlled trials 352
Effects on mortality (MRS 6) 352
Effects on moderately severe disability (MRS 4) 352
Effects on severe disability (MRS 5) 353
Effect on MRS 0 to 3 (good outcome) 353
Effect of timing of surgery on outcome 353
Dominant hemisphere involvement 353
Additional evidence 353
Limitations of the randomized controlled trials 353
Surgical Technique 354
Postoperative Management 354
Complications of Decompressive Craniectomy 354
Decompressive Craniectomy for Malignant Middle Cerebral Artery Stroke: A Case Illustration 354
ISCHEMIC POSTERIOR FOSSA STROKE (INFRATENTORIAL) 354
Existing Evidence 355
Surgical Technique 356
Decompressive Craniectomy for Posterior Fossa Ischemic Stroke: A Case Illustration 356
HEMORRHAGIC STROKE 356
Overview of Intracerebral Hemorrhage 356
Pathophysiology of Spontaneous Intracerebral Hemorrhage 356
Decompressive Craniectomy for Supratentorial Intracerebral Hemorrhage 357
Decompressive Craniectomy for Hemorrhagic Stroke: A Case Illustration 357
Decompressive Craniectomy for Posterior Fossa Hemorrhage 357
STATE OF CURRENT KNOWLEDGE AND FUTURE TRIAL AREAS 358
ACKNOWLEDGMENTS 358
REFERENCES 358
Direct Versus Indirect Bypass for Moyamoya Disease 361
Key points 361
INTRODUCTION 361
PATIENT EVALUATION OVERVIEW 362
NONSURGICAL TREATMENT OPTIONS 362
SURGICAL TREATMENT OPTIONS 362
Direct Bypass Technique 362
Indirect Bypass Techniques 365
INDIRECT TECHNIQUES USING DISTANT TISSUE 367
DISCUSSION 370
Benefits of Revascularization 370
Direct Versus Indirect Bypass and Outcomes 370
SUMMARY 372
REFERENCES 373
Flow Diversion after Aneurysmal Subarachnoid Hemorrhage 375
Key points 375
INTERNATIONAL SUBARACHNOID ANEURYSM TRIAL ESTABLISHED ENDOVASCULAR TREATMENT AS THE PRIMARY TREATMENT OF RUPTURED ANEURYSMS 375
WHO GETS CLIPPED AFTER THE INTERNATIONAL SUBARACHNOID ANEURYSM TRIAL? 376
ENDOVASCULAR DEVICES ARE DEVELOPING AT A RAPID PACE TO ENABLE TREATMENT OF MORE COMPLEX ANEURYSM MORPHOLOGIES AND TO DECREA ... 376
OUR PROTOCOL FOR ANEURYSMAL SUBARACHNOID HEMORRHAGE 376
WHAT IS FLOW DIVERSION? 377
FLOW DIVERSION IS NOT THE PREFERRED TREATMENT AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE 377
PATIENT SELECTION FOR FLOW DIVERSION AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE 377
ANTIPLATELET THERAPY 377
FLOW-DIVERSION TECHNIQUE 377
OUR EXPERIENCE WITH FLOW DIVERSION AFTER SUBARACHNOID HEMORRHAGE 378
REVIEW OF THE LITERATURE 381
Hemorrhagic Risk with Dual Antiplatelet Agents After Subarachnoid Hemorrhage 385
Blister Aneurysms 385
Risk of Dome Protection and Delayed Flow Diversion After Aneurysmal Rupture 385
Flow Diversion Is Associated with Better Long-term Aneurysm Occlusion Rates 386
Coiling-assisted Flow Diversion 386
SHIELD TECHNOLOGY MAY INCREASE THE SAFETY OF FLOW DIVERSION IN ANEURYSMAL SUBARACHNOID HEMORRHAGE 386
SUMMARY 386
DISCLOSURE 386
REFERENCES 387
Management of Small Incidental Intracranial Aneurysms 389
Key points 389
INTRODUCTION 389
PATIENT EVALUATION OVERVIEW 389
MEDICAL TREATMENT OPTIONS 392
SURGICAL TREATMENT OPTIONS 392
EVALUATION OF OUTCOME AND LONG-TERM RECOMMENDATIONS 393
SUMMARY/DISCUSSION 395
REFERENCES 395
Surgical Management of Incidental Gliomas 397
Key points 397
INTRODUCTION 397
GLIOMA GENETICS 398
DIAGNOSTIC IMAGING 398
STEREOTACTIC BIOPSY 399
MICROSURGICAL RESECTION 399
FUNCTIONAL MAPPING 401
MALIGNANT TRANSFORMATION 402
ADVANCED TECHNOLOGIES 403
SUMMARY 403
REFERENCES 403
Reoperation for Recurrent Glioblastoma Multiforme 407
Key points 407
INTRODUCTION 407
METHODS 408
RESULTS 408
DISCUSSION 409
Inclusion and Exclusion Criteria 409
Indications for Surgery 414
Survival Following Reoperation for Recurrent or Progressive Glioblastoma Multiforme 414
Extent of resection 424
Progression-free survival 424
Complications 424
Bias 425
SUMMARY 425
ACKNOWLEDGMENTS 425
REFERENCES 425
Surgical Treatment of Trigeminal Neuralgia 429
Key points 429
INTRODUCTION 429
MICROVASCULAR DECOMPRESSION 429
Success Rates 429
Complications 430
PERCUTANEOUS TREATMENTS 431
Percutaneous Radiofrequency Rhizotomy 431
Success rates 431
Complications 431
Percutaneous Glycerol Rhizotomy 432
Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele 439
Key points 439
INTRODUCTION 439
POSTNATAL REPAIR OF MYELOMENINGOCELE 440
PRENATAL DIAGNOSIS OF MYELOMENINGOCELE 441
Prenatal Imaging Assessment: Fetal MRI 443
PRENATAL REPAIR OF MYELOMENINGOCELE 443
Outcomes of Postnatal Versus Prenatal Myelomeningocele Correction 444
Future Perspectives of Myelomeningocele Treatment 446
SUMMARY 447
REFERENCES 447
Index 449